Gemmer Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Gemmer Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-393	Closed	-$228K	–	180
2025 Q4	$228K	Sell	393 -30	-7%	-$17K	0.02%	162
2025 Q3	$205K	Buy	+423	New	+$197K	0.02%	165
2025 Q2	–	Sell	-464	Closed	-$231K	–	168
2025 Q1	$231K	Hold	464	–	–	0.02%	138
2024 Q4	$241K	Buy	464 +37	+9%	+$20.3K	0.02%	133
2024 Q3	$264K	Hold	427	–	–	0.03%	127
2024 Q2	$236K	Sell	427 -97	-19%	-$55.6K	0.03%	126
2024 Q1	$305K	Buy	524 +97	+23%	+$54.4K	0.04%	103
2023 Q4	$227K	Buy	427 +1	+0.2%	+$484	0.03%	123
2023 Q3	$216K	Sell	426 -60	-12%	-$32K	0.03%	118
2023 Q2	$254K	Buy	486 +60	+14%	+$32.4K	0.03%	110
2023 Q1	$246K	Hold	426	–	–	0.04%	109
2022 Q4	$235K	Sell	426 -25	-6%	-$13.2K	0.04%	104
2022 Q3	$229K	Buy	+451	New	+$252K	0.04%	108
2022 Q2	–	Sell	-201	Closed	-$118K	–	1038
2022 Q1	$118K	Sell	201 -39	-16%	-$22.4K	0.01%	157
2021 Q4	$160K	Hold	240	–	–	0.02%	137
2021 Q3	$137K	Hold	240	–	–	0.02%	134
2021 Q2	$121K	Buy	240 +6	+3%	+$2.83K	0.02%	156
2021 Q1	$107K	Hold	234	–	–	0.02%	154
2020 Q4	$109K	Hold	234	–	–	0.02%	134
2020 Q3	$103K	Hold	234	–	–	0.02%	121
2020 Q2	$85K	Hold	234	–	–	0.02%	143
2020 Q1	$66K	Hold	234	–	–	0.02%	148
2019 Q4	$76K	Hold	234	–	–	0.02%	152
2019 Q3	$68K	Buy	234 +8	+4%	+$2.29K	0.02%	160
2019 Q2	$66K	Hold	226	–	–	0.02%	164
2019 Q1	$62K	Sell	226 -22	-9%	-$5.47K	0.02%	167
2018 Q4	$55K	Hold	248	–	–	0.02%	165
2018 Q3	$61K	Hold	248	–	–	0.02%	161
2018 Q2	$51K	Hold	248	–	–	0.02%	182
2018 Q1	$51K	Hold	248	–	–	0.02%	184
2017 Q4	$47K	Sell	248 -40	-14%	-$7.66K	0.02%	198
2017 Q3	$54K	Hold	288	–	–	0.02%	167
2017 Q2	$50K	Hold	288	–	–	0.02%	176
2017 Q1	$44K	Hold	288	–	–	0.02%	190
2016 Q4	$41K	Hold	288	–	–	0.02%	188
2016 Q3	$46K	Hold	288	–	–	0.02%	177
2016 Q2	$43K	Hold	288	–	–	0.02%	182
2016 Q1	$40K	Hold	288	–	–	0.02%	190
2015 Q4	$41K	Sell	288 -30	-9%	-$4K	0.02%	179
2015 Q3	$39K	Hold	318	–	–	0.02%	204
2015 Q2	$41K	Hold	318	–	–	0.02%	193
2015 Q1	$43K	Hold	318	–	–	0.03%	195
2014 Q4	$40K	Hold	318	–	–	0.03%	196
2014 Q3	$39K	Buy	318 +29	+10%	+$3.53K	0.03%	197
2014 Q2	$34K	Buy	289 +41	+17%	+$4.83K	0.02%	209
2014 Q1	$30K	Buy	+248	New	+$29.5K	0.02%	227

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Gemmer Asset Management's TMO Position: Q1 2026 in Review

Gemmer Asset Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 393 shares — an estimated $228K sold.

Gemmer Asset Management first reported a position in TMO in Q1 2014 and held it in 46 quarters. The position peaked at $305K in Q1 2024. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Gemmer Asset Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Gemmer Asset Management sold 393 Thermo Fisher Scientific shares in Q1 2026, an estimated $228K.
Gemmer Asset Management first reported a position in Thermo Fisher Scientific in Q1 2014 and held it in 46 quarters.
Gemmer Asset Management's Thermo Fisher Scientific position peaked at $305K in Q1 2024.
2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Gemmer Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.